Chemistry:DESOXY

From HandWiki

4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines.[1] It is commonly referred to as DESOXY.[1] DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.[1]

Effects

Dosage

A typical dosage is within the range of 40–120 mg and lasts 6–8 hours.[2]

Pharmacology

DESOXY acts as a serotonin 5-HT2 receptor agonist.[3]

In 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.

DESOXY is also an isomer of 2C-D which makes it a schedule 1 drug in the United States.

See also

References

  1. ↑ 1.0 1.1 1.2 The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. 1. Berkeley: Transform Press. 2011. pp. 46–47. ISBN 978-0-9630096-3-0. https://archive.org/details/shulgin-index-vol-1/page/46/mode/1up?view=theater. Retrieved 2 November 2024. 
  2. ↑ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal052.shtml. 
  3. ↑ "Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential". Nat Commun 14 (1). December 2023. doi:10.1038/s41467-023-44016-1. PMID 38102107. Bibcode: 2023NatCo..14.8221W. 

Template:Psychedelics



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:DESOXY&oldid=4176499"